Invention Grant
- Patent Title: HLA peptide therapy
- Patent Title (中): HLA肽治疗
-
Application No.: US12299801Application Date: 2007-05-09
-
Publication No.: US08715680B2Publication Date: 2014-05-06
- Inventor: Simon Ball , Bernard Maillere
- Applicant: Simon Ball , Bernard Maillere
- Applicant Address: GB Birmingham
- Assignee: The University of Birmingham
- Current Assignee: The University of Birmingham
- Current Assignee Address: GB Birmingham
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jeanne M. DiGiorgio
- Priority: GB0609121.9 20060509
- International Application: PCT/GB2007/001690 WO 20070509
- International Announcement: WO2007/129093 WO 20071115
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/00 ; A61K38/04 ; A61K38/16 ; C07H21/04
Abstract:
The invention provides polypeptides derived from a major histocompatibility complex (MHC) class I human leukocyte antigen (HLA), such as HLA-A2, and derivatives or analogues thereof. The polypeptides, derivatives and analogues can be used to treat or prevent allosensitisation, such as the treatment or prevention of allograft rejection.
Public/Granted literature
- US20100215619A1 HLA PEPTIDE THERAPY Public/Granted day:2010-08-26
Information query
